Cannabidiol (CBD) Nutraceuticals Market Size to Surpass USD 47.28 billion by 2032
The 2022 global market size for Cannabidiol (CBD) Nutraceuticals Market amounted to USD 9.88 billion and is projected to reach USD 47.28 billion by 2032, marking a substantial revenue compound annual growth rate (CAGR) of 19% throughout the forecast period. The increasing incidence of chronic diseases, including diabetes, cancer, and arthritis, is a key driver for the growing demand for CBD nutraceuticals. Research indicates that CBD possesses anti-inflammatory effects, which can aid in alleviating pain and discomfort associated with these ailments.